Infectious Disease

Current Project	Investigator	Site
A Multicentre Concealed‐Allocation Parallel‐Group Blinded Randomized Controlled Trial to Ascertain the Effect of High‐Dose Intravenous Vitamin C Compared to Placebo on Mortality or Persistent Organ Dysfunction at 28 Days in Septic Intensive Care Unit Patients (LOVIT PROPER)	Dr. J Kutsogiannis	RAH-ICU
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Recombinant Human Plasma Gelsolin with Standard of Care For Moderate-To-Severe Ards Due To Pneumonia or Other Infections	Dr. J Kutsogiannis	RAH-ICU
BALANCE+	Dr. W Sligl	GSICU
FISSH	Dr. J Senaratne	GNH-ICU
Lessening Organ Dysfunction with VITamin C; A Multicentre Concealed-Allocation Parallel-Group Blinded Randomized Controlled Trial to Ascertain the Effect of High-Dose Intravenous Vitamin C Compared to Placebo on Mortality or Persistent Organ Dysfunction at 28 Days in Hospitalized Patients with COVID-19 (Lovit-Covid)	Dr. J Kutsogiannis	RAH-ICU
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)	Dr. J Kutsogiannis Dr. W Sligl	GSICU RAH-ICU